Wednesday, September 23, 2026

RLI Corp. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

RLI Corp. And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

2. Cardtronics plc

23% sales growth and 5.04% return on equity

Cardtronics plc provides automated consumer financial services through its network of automated teller machines (ATMs) and multi-function financial services kiosks.

Cardtronics plc's sales growth this year is anticipated to be 10.2% and 5.6% for next year.

Year-on-year quarterly revenue growth declined by 18.9%, now sitting on 1.09B for the twelve trailing months.

Cardtronics plc's sales growth for the next quarter is 23%. The company's growth estimates for the present quarter and the next is a negative 23.8% and 192.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.04%.

Cardtronics plc's Stock Yearly Top and Bottom Value

Cardtronics plc's stock is valued at $38.80 at 20:22 EST, under its 52-week high of $42.09 and way higher than its 52-week low of $16.46.

Cardtronics plc's Moving Average

Cardtronics plc's value is above its 50-day moving average of $38.73 and way above its 200-day moving average of $31.86.

3. Enbridge

8.4% sales growth and 5.11% return on equity

Enbridge Inc. operates as an energy infrastructure company in Canada and the United States.

Enbridge's sales growth this year is expected to be 6.7% and 5.5% for next year.

Year-on-year quarterly revenue growth declined by 19%, now sitting on 39.09B for the twelve trailing months.

Enbridge's sales growth for the next quarter is 8.4%. The company's growth estimates for the current quarter and the next is 22.2% and 54.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 5.11%.

Volatility

Enbridge's last day, last week, and last month's current volatility was 0.59%, 0.52%, and 0.74%, respectively.

Enbridge's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 0.67% (day), 1.09% (last week), and 1.39% (last month), respectively.

Enbridge's Stock Yearly Top and Bottom Value

Enbridge's stock is valued at $37.32 at 20:22 EST, above its 52-week high of $37.31.

Enbridge's Moving Average

Enbridge's value is higher than its 50-day moving average of $35.79 and way higher than its 200-day moving average of $32.57.

Previous days news about Enbridge

Enbridge’s great lakes pipeline is ‘nonnegotiable’ for Canada. According to Bloomberg Quint on Tuesday, 13 April, "To address concerns over a potential spill, Calgary-based Enbridge is building a tunnel for the pipeline under the Straits of Mackinac between Michigan's upper and lower peninsulas. ", "In a recent interview, Chief Executive Officer Al Monaco argued the tunnel project is exactly the kind of infrastructure upgrade Biden is pushing for, and said that Enbridge is also lobbying the U.S. government on the matter."

According to Bloomberg Quint on Thursday, 15 April, "Pipeline operator Enbridge Inc. and Energy Transfer LP stand to benefit, BNEF said."

4. RLI Corp.

9.4% sales growth and 14.74% return on equity

RLI Corp., an insurance holding company, underwrites property and casualty insurance in the United States and internationally.

RLI Corp.'s sales growth this year is expected to be 9.7% and 6.9% for next year.

Year-on-year quarterly revenue growth grew by 15%, now sitting on 983.63M for the twelve trailing months.

RLI Corp.'s sales growth for the next quarter is 9.4%. The company's growth estimates for the ongoing quarter and the next is a negative 0% and negative -7.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.74%.

Volatility

RLI Corp.'s last day, last week, and last month's current volatility was 0.45%, 0.56%, and 1.14%, respectively.

RLI Corp.'s current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.83% (day), 1.77% (last week), and 2.38% (last month), respectively.

RLI Corp.'s Stock Yearly Top and Bottom Value

RLI Corp.'s stock is valued at $113.02 at 20:22 EST, below its 52-week high of $117.84 and way higher than its 52-week low of $66.31.

RLI Corp.'s Moving Average

RLI Corp.'s worth is higher than its 50-day moving average of $109.84 and way above its 200-day moving average of $99.79.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Frontier AI Slowdown Call Splits Industry, Rattles Capex-Sensitive Markets
Anthropic's Dario Amodei publicly called for a coordinated global slowdown in frontier AI development, a stance Microsoft echoed with a 'humanist' AI code of conduct, but Nvidia and Meta's CEOs rejected any coordinated pause days later, exposing a widening rift between safety-focused and growth-focused AI leaders. The dispute landed amid growing financial scrutiny of AI infrastructure spending — a hyperscaler capex analysis, FTC warnings against antitrust waivers for AI firms, and an 8.6% single-day stock drop in GE Vernova tied directly to the slowdown remarks — signaling investors are newly nervous about whether the AI capex boom (including Alphabet's projected $701B revenue narrative) can be justified if the pace of development itself becomes contested.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,983
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,983 facts checked against source5,304 source documents archived
Query this data → isubstrate.com